Celgene Corporation to Announce Third Quarter 2015 Results on November 5, 2015
October 01 2015 - 8:30AM
Business Wire
Celgene Corporation (NASDAQ:CELG) will host a conference call
and live audio webcast on Thursday, November 5, 2015 at 9 a.m. ET
to discuss third quarter of 2015 financial and operational results.
The third quarter will include the financial and operational
results of Receptos Inc. following the August 27, 2015 close of the
acquisition. The webcast can be accessed from the Investor
Relations page at www.celgene.com.
About Celgene
Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company engaged primarily in
the discovery, development and commercialization of innovative
therapies for the treatment of cancer and inflammatory diseases
through gene and protein regulation. For more information, please
visit www.celgene.com. Follow Celgene on Social Media: @Celgene,
Pinterest, LinkedIn and YouTube.
Forward-Looking Statements
This press release contains forward-looking statements, which
are generally statements that are not historical facts.
Forward-looking statements can be identified by the words
"expects," "anticipates," "believes," "intends," "estimates,"
"plans," "will," “outlook” and similar expressions. Forward-looking
statements are based on management’s current plans, estimates,
assumptions and projections, and speak only as of the date they are
made. We undertake no obligation to update any forward-looking
statement in light of new information or future events, except as
otherwise required by law. Forward-looking statements involve
inherent risks and uncertainties, most of which are difficult to
predict and are generally beyond our control. Actual results or
outcomes may differ materially from those implied by the
forward-looking statements as a result of the impact of a number of
factors, many of which are discussed in more detail in our Annual
Report on Form 10-K and our other reports filed with the Securities
and Exchange Commission.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151001005126/en/
Celgene CorporationPatrick E. Flanigan III, 908-673-9969VP,
Investor RelationsorCelgene CorporationBrian Gill, 908-673-9530VP,
Corporate Communications
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Apr 2023 to Apr 2024